Malenge MM, Maaland AF, Repetto-Llamazares A, Middleton B, et al. Anti-CD37 radioimmunotherapy with 177Lu-NNV003 synergizes with the PARP inhibitor olaparib in treatment of non-Hodgkin's lymphoma in vitro. PLoS One 2022;17:e0267543.
PMID: 35486574